Scispace (Formerly Typeset)
  1. Home
  2. Journals
  3. Diabetes Research and Clinical Practice
  4. 2005
  1. Home
  2. Journals
  3. Diabetes Research and Clinical Practice
  4. 2005
Showing papers in "Diabetes Research and Clinical Practice in 2005"
Journal Article•10.1016/J.DIABRES.2004.09.004•
Advanced glycation endproducts—role in pathology of diabetic complications

[...]

Nessar Ahmed1•
Manchester Metropolitan University1
01 Jan 2005-Diabetes Research and Clinical Practice
TL;DR: The chemistry of glycation and AGEs is introduced and the mechanisms by which they mediate their toxicity are examined and the role of A GEs in the pathogenesis of retinopathy, cataract, atherosclerosis, neuropathy, nephropathy, diabetic embryopathy and impaired wound healing are considered.

1,530 citations

Journal Article•10.1016/J.DIABRES.2004.11.007•
Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6

[...]

Hye Soon Park1, Jung Yul Park2, Rina Yu1•
University of Ulsan1, Korea University2
01 Jul 2005-Diabetes Research and Clinical Practice
TL;DR: The positive associations of obesity and visceral adiposity with elevated cytokine levels suggest the importance of reducing obesity and abdominal fat distribution to prevent elevations in cytokine Levels.

885 citations

Journal Article•10.1016/J.DIABRES.2004.06.010•
Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males

[...]

Kinori Kosaka, Mitsuihiko Noda, Takeshi Kuzuya
01 Feb 2005-Diabetes Research and Clinical Practice
TL;DR: Lifestyle intervention aimed at achieving ideal body weight in men with IGT is effective and can be conducted in an outpatient clinic setting, and a linear correlation between the incidence of diabetes and the BMI values was revealed with the exception of the DaQing Study.

692 citations

Journal Article•10.1016/J.DIABRES.2005.03.024•
Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study)

[...]

Stewart B. Harris1, Jean-Marie Ekoé2, Yola Zdanowicz, Susan Webster-Bogaert1•
University of Western Ontario1, Université de Montréal2
01 Oct 2005-Diabetes Research and Clinical Practice
TL;DR: The results underscore the complexity of primary care management of T2DM and suggest that current treatment approaches are not intensive enough for a large proportion of patients especially those with longer duration of disease.

254 citations

Journal Article•10.1016/J.DIABRES.2004.09.007•
Socioeconomic status and diagnosed diabetes incidence.

[...]

Jessica M. Robbins, Viola Vaccarino1, Viola Vaccarino2, Heping Zhang2, Stanislav V. Kasl2 •
Emory University1, Yale University2
01 Jun 2005-Diabetes Research and Clinical Practice
TL;DR: SES, assessed with any of three common measures, is a risk factor for diagnosed diabetes in women and among men these associations are less consistent.

205 citations

Journal Article•10.1016/J.DIABRES.2004.07.022•
The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population

[...]

G. Neil Thomas1, Sai Yin Ho1, Edward D Janus1, Karen S.L. Lam1, Anthony J. Hedley1, Tai Hing Lam1 •
University of Hong Kong1
01 Mar 2005-Diabetes Research and Clinical Practice
TL;DR: The high prevalence of the metabolic syndrome in adult Hong Kong Chinese, particularly in the elderly, forewarns a rapidly increasing problem in Mainland China, and other Asian populations, which may have overwhelming public health ramifications.

192 citations

Journal Article•10.1016/J.DIABRES.2005.03.028•
Hand grip strength in patients with type 2 diabetes mellitus.

[...]

Ercan Cetinus1, Mehmet Akif Buyukbese1, Murat Uzel1, Hasan Cetin Ekerbicer1, Ahmet Karaoguz1 •
Kahramanmaraş Sütçü İmam University1
01 Dec 2005-Diabetes Research and Clinical Practice
TL;DR: Hand grip strength and key pinch power values were found to be lower in patients with T2DM than in age-matched control subjects, and physicians should be aware of this.

174 citations

Journal Article•10.1016/J.DIABRES.2004.12.005•
Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey

[...]

M. Malik, A. Bakir, B. Abi Saab, Gojka Roglic1, Hilary King1 •
World Health Organization1
01 Aug 2005-Diabetes Research and Clinical Practice
TL;DR: Diabetes, obesity and hypertension are extremely prevalent in the adult population of the United Arab Emirates and prompt action is required to avert a major public health crisis due to the long-term complications of diabetes in the near future.

171 citations

Journal Article•10.1016/J.DIABRES.2005.02.016•
Derivation and validation of diabetes risk score for urban Asian Indians

[...]

A. Ramachandran, Chamukuttan Snehalatha, V. Vijay, Nicholas J. Wareham1, Stephen Colagiuri2 •
Medical Research Council1, Diabetes Australia2
01 Oct 2005-Diabetes Research and Clinical Practice
TL;DR: A diabetes risk score involving simple non-biochemical measurements was developed and validated in a native Asian Indian population and could play an important role as the first step in the process of identifying individuals with an increased likelihood of having prevalent but undiagnosed diabetes.

160 citations

Journal Article•10.1016/J.DIABRES.2005.02.010•
Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations.

[...]

Lawrence A. Lavery1, Robert P. Wunderlich, Jeffrey L. Tredwell•
Georgetown University1
01 Oct 2005-Diabetes Research and Clinical Practice
TL;DR: A population-based screening and treatment program for the diabetic foot can dramatically reduce hospitalizations and clinical outcomes.

159 citations

Journal Article•10.1016/J.DIABRES.2004.11.018•
Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela.

[...]

Hermes Florez1, Hermes Florez2, Hermes Florez3, Egle Silva2, Virginia Fernández2, Elena Ryder2, Tulio Sulbarán2, Gilberto Campos2, Gustavo Calmon2, Emilio Clavel2, Sumaya Castillo-Florez1, Ronald N. Goldberg1 •
University of Miami1, University of Zulia2, Veterans Health Administration3
01 Jul 2005-Diabetes Research and Clinical Practice
TL;DR: It is suggested that MS is found in approximately one-third of the Venezuelan adult population in Zulia State, with higher prevalence in men related to the presence of dyslipidemia, and lifestyle interventions in MS subjects are needed in Venezuela to halt the burden of CV disease and diabetes.
Journal Article•10.1016/J.DIABRES.2005.02.009•
Clinical features of non-diabetic renal diseases in patients with type 2 diabetes.

[...]

Atsuhito Tone1, Kenichi Shikata1, Mitsuhiro Matsuda, Hitomi Usui1, Shinichi Okada1, Daisuke Ogawa1, Jun Wada1, Hirofumi Makino1 •
Okayama University1
01 Sep 2005-Diabetes Research and Clinical Practice
TL;DR: It is confirmed that the absence of retinopathy and short duration of diabetes are useful clinical indications for renal biopsy in diabetic patients with overt proteinuria.
Journal Article•10.1016/J.DIABRES.2005.03.011•
Prevention and treatment of diabetic nephropathy

[...]

István Wittmann1, Gergő A. Molnár1, Péter Degrell1, Zoltán Wagner1, Mónika Tamaskó1, Boglárka Laczy1, Pál Brasnyó1, László Wagner1, Judit Nagy1 •
University of Pécs1
01 Jun 2005-Diabetes Research and Clinical Practice
TL;DR: Improvement of carbohydrate metabolism with a consequential decrease in the formation of AGE is an important contributor to the prevention and treatment of diabetic nephropathy and atherosclerosis.
Journal Article•10.1016/J.DIABRES.2004.11.015•
High prevalence of metabolic syndrome in Hong Kong Chinese—comparison of three diagnostic criteria

[...]

G. T. C. Ko, Clive S. Cockram1, Chun-Chung Chow1, Vincent T.F. Yeung1, W.B. Chan1, Wing-Yee So1, Norman N. Chan, Juliana Chun-Ngor Chan1 •
The Chinese University of Hong Kong1
01 Aug 2005-Diabetes Research and Clinical Practice
TL;DR: The prevalence of MES in Hong Kong Chinese of working age ranges from 6.1 to 13.4% depending on various diagnostic criteria and the inclusion of albuminuria and insulin resistance by the WHO has made it the most discriminative criterion in identifying at risk individuals in all age groups.
Journal Article•10.1016/J.DIABRES.2004.12.007•
Camel milk as an adjunct to insulin therapy improves long-term glycemic control and reduction in doses of insulin in patients with type-1 diabetes A 1 year randomized controlled trial.

[...]

R.P. Agrawal, R. Beniwal, Dhanpat K. Kochar, F.C. Tuteja, S. K. Ghorui, M. S. Sahani, S Sharma1 •
Maharana Pratap University of Agriculture and Technology1
01 May 2005-Diabetes Research and Clinical Practice
Journal Article•10.1016/J.DIABRES.2005.03.022•
Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus

[...]

Daniel A. Enquobahrie1, Michelle A. Williams1, Chunfang Qiu1, David A. Luthy•
University of Washington1
01 Nov 2005-Diabetes Research and Clinical Practice
TL;DR: A linear component of trend in risk of GDM with increasing plasma TG was noted, and associations between GDM risk and plasma concentrations of other lipids were not evident.
Journal Article•10.1016/J.DIABRES.2004.12.010•
Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes.

[...]

Seung Won Lee1, Kyoung Eun Song1, Dong Sun Shin1, Sung-Min Ahn1, Eun Suk Ha1, Dae Jung Kim1, Moon Suk Nam2, Moon Suk Nam1, Kwan Woo Lee1 •
Ajou University1, Inha University2
01 Aug 2005-Diabetes Research and Clinical Practice
TL;DR: Plasma MMP-2, TIMP-1 and hs-CRP concentrations were significantly increased in type-2 diabetic patients, and were found not to be significantly associated with age, duration of diabetes, blood pressure, or serum lipid concentrations.
Journal Article•10.1016/J.DIABRES.2005.02.013•
A comparison of the monofilament with other testing modalities for foot ulcer susceptibility

[...]

B. Miranda-Palma1, Jay M. Sosenko1, John H. Bowker1, Mark S. Mizel1, Andrew J.M. Boulton1 •
University of Miami1
01 Oct 2005-Diabetes Research and Clinical Practice
TL;DR: The number of testing sites and the proportion needed to be insensate for the optimal assessment of foot ulcer risk with the 10 g monofilament are studied and the sensitivity and specificities are compared with other methodologies.
Journal Article•10.1016/J.DIABRES.2004.07.013•
Prevalence of Type 2 diabetes and central adiposity in La Reunion Island, the REDIA Study.

[...]

François Favier1, Isabelle Jaussent1, Nathalie Le Moullec, Xavier Debussche, Marie-Claude Boyer, Jean-Claude Schwager, Laure Papoz1 •
French Institute of Health and Medical Research1
01 Mar 2005-Diabetes Research and Clinical Practice
TL;DR: It is confirmed that Type 2 diabetes is increasing dramatically in societies in epidemiologic transition and is strongly linked to nutritional status.
Journal Article•10.1016/J.DIABRES.2005.03.031•
Serious diabetes-specific emotional problems and depression in a Croatian-Dutch-English Survey from the European Depression in Diabetes [EDID] Research Consortium

[...]

François Pouwer1, T. Chas Skinner2, Mirjana Pibernik-Okanović, Aartjan T.F. Beekman1, Sue Cradock3, Silvija Szabo, Zeljko Metelko, Frank J. Snoek1 •
VU University Amsterdam1, Leicester Royal Infirmary2, Queen Alexandra Hospital3
01 Nov 2005-Diabetes Research and Clinical Practice
TL;DR: In this paper, the levels of diabetes-specific emotional problems in diabetic individuals with high versus low levels of depression in a sample of 539 outpatients with diabetes (202 Dutch, 185 Croatian and 152 English). Subjects completed the Center for Epidemiological Studies Depression and the Problem Areas in Diabetes scales.
Journal Article•10.1016/J.DIABRES.2004.05.013•
Hypoglycemic effect of Du-zhong (Eucommia ulmoides Oliv.) leaves in streptozotocin-induced diabetic rats.

[...]

Mi-Kyung Lee1, Myung-Joo Kim2, Soo-Yeul Cho3, Sun Ae Park3, Kwan-Kyu Park4, Un Ju Jung1, Hae-Mo Park5, Myung-Sook Choi1 •
Kyungpook National University1, Korea Polytechnic VI Daegu2, Yeungnam University3, Keimyung University4, Sangji University5
01 Jan 2005-Diabetes Research and Clinical Practice
TL;DR: Du-zhong leaves supplement seemed to be helpful to preserve the normal histological appearance of pancreatic islets as well as to preserve insulin-positive beta-cells but it did not reverse the effect of STZ to a great extent.
Journal Article•10.1016/J.DIABRES.2005.02.011•
Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes.

[...]

Glyn Belcher1, Ceri Lambert1, Gareth Edwards1, Richard Urquhart1, David R Matthews2 •
Takeda Pharmaceutical Company1, Churchill Hospital2
01 Oct 2005-Diabetes Research and Clinical Practice
TL;DR: All three drugs are safe, but that tolerability profiles vary, and each treatment provides an alternative therapy for type 2 diabetes, dependent on the particular needs of individual patients.
Journal Article•10.1016/J.DIABRES.2004.08.006•
Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density

[...]

Kiyoshi Suzuki1, Takeshi Kurose, Makoto Takizawa1, Masahiro Maruyama1, Kenji Ushikawa1, Munetsugu Kikuyama, Chieko Sugimoto, Yutaka Seino2, Shinya Nagamatsu1, Hitoshi Ishida1 •
Kyorin University1, Kyoto University2
01 May 2005-Diabetes Research and Clinical Practice
TL;DR: It seems probable that OCIF/OPG has a suppressive role on the increased bone resorption to prevent further loss of the skeletal bone mass in type 2 diabetic patients.
Journal Article•10.1016/J.DIABRES.2004.10.010•
Increased levels of platelet-derived microparticles in patients with diabetic retinopathy.

[...]

Nahoko Ogata1, Masahito Imaizumi1, Shosaku Nomura1, Akira Shozu1, Miwa Arichi1, Masato Matsuoka1, Miyo Matsumura1 •
Kansai Medical University1
01 Jun 2005-Diabetes Research and Clinical Practice
TL;DR: The PMPs levels and the expression of platelet CD62P and CD63 were measured and high correlations indicate that increased levels of PMPs may accelerate diabetic retinopathy.
Journal Article•10.1016/J.DIABRES.2005.03.008•
Correlation of serum ghrelin levels with body mass index and carbohydrate metabolism in patients treated with atypical antipsychotics.

[...]

Éva Palik1, K.D. Birkás1, Gabor Faludi1, István Karádi1, Károly Cseh •
Semmelweis University1
01 Jun 2005-Diabetes Research and Clinical Practice
TL;DR: The aim of this study was to determine ghrelin levels of atypical antipsychotic-treated patients in relationship with their body mass index (BMI) and carbohydrate metabolism, and to find the orexigen effect of elevated serum gh Relin levels can contribute to the weight-gain and high diabetes prevalence associated with atypicals antipsychotics.
Journal Article•10.1016/J.DIABRES.2004.11.001•
Predictive values of anthropometric measurements for multiple metabolic disorders in Asian populations.

[...]

Kuninori Shiwaku1, Erdembileg Anuurad1, Byambaa Enkhmaa1, Akiko Nogi1, Keiko Kitajima1, Masayuki Yamasaki1, Toshimi Yoneyama1, Tsendsuren Oyunsuren2, Yosuke Yamane1 •
Shimane University1, Mongolian Academy of Sciences2
01 Jul 2005-Diabetes Research and Clinical Practice
TL;DR: The present study suggests that BMI and WC were useful for predicting multiple metabolic disorders in non-diabetic Mongolians and Japanese, while the use of plasma triglyceride and HDL-cholesterol levels in combination with BMI andWC may enhance the ability of predicting metabolic parameters in the Japanese.
Journal Article•10.1016/J.DIABRES.2004.07.021•
Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.

[...]

J Cederholm, Björn Eliasson1, Peter M. Nilsson, Lars Weiss, S Gudbjornsdottir1 •
Sahlgrenska University Hospital1
01 Mar 2005-Diabetes Research and Clinical Practice
TL;DR: High HbA(1c), BP and BMI were independent risk factors for the development of microalbuminuria in types 1 and 2 diabetic patients.
Journal Article•10.1016/J.DIABRES.2004.10.007•
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome

[...]

Giuseppe Derosa1, Arrigo F G Cicero2, Antonio Vittorino Gaddi2, Pietro D. Ragonesi, Mario N. Piccinni1, Elena Fogari1, Sibilla A T Salvadeo1, Leonardina Ciccarelli1, Roberto Fogari1 •
University of Pavia1, University of Bologna2
01 Jul 2005-Diabetes Research and Clinical Practice
TL;DR: The addition of a thiazolinedione to glimepiride treatment in type 2 diabetic subjects with the metabolic syndrome is associated with a slight but significant reduction of PAI-1 value, related to a similar reduction in insulinresistance.
Journal Article•10.1016/J.DIABRES.2005.06.002•
Walking for exercise—does three times per week influence risk factors in type 2 diabetes?

[...]

Tomas Fritz1, Per Wändell1, Hans Åberg1, Peter Engfeldt2•
Karolinska Institutet1, Örebro University2
06 Jul 2005-Diabetes Research and Clinical Practice
TL;DR: It is suggested that an increase of regular physical activity equivalent to 45 min of walking 3 days/week may suffice to improve systolic and diastolic blood pressure, lipid metabolism and BMI in patients with type 2 diabetes.
Journal Article•10.1016/J.DIABRES.2004.09.018•
Effects of repaglinide on oxidative stress in tissues of diabetic rabbits.

[...]

Anna Gumieniczek1•
Medical University of Lublin1
01 May 2005-Diabetes Research and Clinical Practice
TL;DR: It is shown that repaglinide produces measurable antioxidative effects at therapeutic dose and did not affect the glucose level but reduced to some extent the oxidative stress enhanced by chronic hyperglycemia.
...

Tools

SciSpace AgentBiomedical AgentSciSpace RecruitSciSpace for EnterpriseAgent GalleryChat with PDFLiterature ReviewAI WriterFind TopicsParaphraserCitation GeneratorExtract DataAI DetectorCitation Booster

Learn

ResourcesLive Workshops

SciSpace

CareersSupportBrowse PapersPricingSciSpace Affiliate ProgramCancellation & Refund PolicyTermsPrivacyData Sources

Directories

PapersTopicsJournalsAuthorsConferencesInstitutionsCitation StylesWriting templates

Extension & Apps

SciSpace Chrome ExtensionSciSpace Mobile App

Contact

support@scispace.com
SciSpace

© 2026 | PubGenius Inc. | Suite # 217 691 S Milpitas Blvd Milpitas CA 95035, USA

soc2
Secured by Delve